Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways
Open Access
- 31 December 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (1) , 696
Abstract
Disabled-2 (DAB2), a key adaptor protein in clathrin mediated endocytosis, is implicated in the regulation of key signalling pathways involved in homeostasis, cell positioning and epithelial to mesenchymal transition (EMT). It was initially identified as a tumour suppressor implicated in the initiation of ovarian cancer, but was subsequently linked to many other cancer types. DAB2 contains key functional domains which allow it to negatively regulate key signalling pathways including the mitogen activated protein kinase (MAPK), wingless/integrated (Wnt) and transforming growth factor beta (TGFβ) pathways. Loss of DAB2 is primarily associated with activation of these pathways and tumour progression, however this review also explores studies which demonstrate the complex nature of DAB2 function with pro-tumorigenic effects. A recent strong interest in microRNAs (miRNA) in cancer has identified DAB2 as a common target. This has reignited an interest in DAB2 research in cancer. Transcriptomics of tumour associated macrophages (TAMs) has also identified a pro-metastatic role of DAB2 in the tumour microenvironment. This review will cover the broad depth literature on the tumour suppressor role of DAB2, highlighting its complex relationships with different pathways. Furthermore, it will explore recent findings which suggest DAB2 has a more complex role in cancer than initially thought.Keywords
Funding Information
- Ovarian Cancer Research Foundation, Australia
This publication has 115 references indexed in Scilit:
- Disabled‐2 (Dab2) inhibits Wnt/β‐catenin signalling by binding LRP6 and promoting its internalization through clathrinThe EMBO Journal, 2012
- The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancerOncogene, 2012
- Negative Regulation of the Endocytic Adaptor Disabled-2 (Dab2) in MitosisJournal of Biological Chemistry, 2011
- Type II Transforming Growth Factor-β Receptor Recycling Is Dependent upon the Clathrin Adaptor Protein Dab2Molecular Biology of the Cell, 2010
- Disabled-2 downregulation promotes epithelial-to-mesenchymal transitionBritish Journal of Cancer, 2010
- TGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEINature Cell Biology, 2010
- Quantitative proteomics identifies a Dab2/integrin module regulating cell migrationJournal of Cell Biology, 2009
- Dab2 stabilizes Axin and attenuates Wnt/β-catenin signaling by preventing protein phosphatase 1 (PP1)–Axin interactionsOncogene, 2009
- Focal adhesion disassembly requires clathrin‐dependent endocytosis of integrinsFEBS Letters, 2009
- Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinomaJournal of Clinical Investigation, 2007